Welcome

I AM A ...

I accept the Privacy Statement and I agree to comply with it. View our Privacy Statement.

This website uses cookies to better understand user behavior and provide the best experience. By continuing to use this website, you are consenting to the placement and retrieval of cookies on your computer by this website. Cookies will be stored for 90 days.

Never show this.

Company Highlight: Encompass Health

March 2022

Ticker: (EHC)

Year Founded: 1984

Headquarters:
Birmingham, Alabama

Encompass Health

Encompass Health is a post-acute healthcare provider offering Inpatient Rehab Facilities (IRF) and Home Health & Hospice services. It is the leading operator of freestanding IRF, accepting patients after a qualifying event, such as a stroke or hip replacement, and when additional rehab or care is required. IRFs typically compete with Skilled Nursing Facilities but provide a higher level of care as they are subject to more stringent requirements1 such as three hours of daily physical therapy. Encompass Health’s Home Health and Hospice business focuses on nursing, physical, occupational and speech therapies, and end of life care.

Ticker:
(EHC)

Year
Founded:
1984

Headquarters:
Birmingham,
Alabama

Encompass Health

Encompass Health is a post-acute healthcare provider offering Inpatient Rehab Facilities (IRF) and Home Health & Hospice services. It is the leading operator of freestanding IRF, accepting patients after a qualifying event, such as a stroke or hip replacement, and when additional rehab or care is required. IRFs typically compete with Skilled Nursing Facilities but provide a higher level of care as they are subject to more stringent requirements1 such as three hours of daily physical therapy. Encompass Health’s Home Health and Hospice business focuses on nursing, physical, occupational and speech therapies, and end of life care.

Know What You Own

We added Encompass Health to the Jensen Quality Value Strategy in October 2017 due to its attractive valuation, competitive advantages, and growth prospects. Notably, EHC provides a nondiscretionary service that we believe is likely to provide portfolio stability in most market environments.

The company’s primary competitive advantages include a market-leading position in an industry with relatively high barriers to entry, IT-enabled solutions that provide margin expansion and growth opportunities (e.g., clinical and operational software), and a solid management team with a track record of consistent execution despite numerous industrywide regulatory changes.

Over the past decade, Encompass Health has proven its ability to provide cost-efficient, quality care, treating higher acuity patients at a lower average cost, with higher discharge and lower readmissions rates in comparison to its peers. This is especially significant as a majority of EHC’s revenue stems from Medicare/Medicaid reimbursement based on the quality and cost of care.

Outlook

We believe Encompass Health has attractive, long-term growth prospects resulting from the demographic tailwinds of an aging population, industry consolidation and capacity expansion. Additionally, clinical collaboration efforts between IRF and Home Health & Hospice services have driven growth as patients typically require home health care after leaving a facility.

Recently, EHC has been out of favor due to pandemic-related challenges, including the inability to conduct home health visits and pauses in elective procedures as hospitals prioritize care for emergent needs. The company has also been impacted by industrywide nursing shortages, which resulted in increased operating expenses, pressuring profitability. At Jensen, it is our belief that these challenges are shorter-term in nature and we expect demand for services to return to pre-pandemic levels or higher. The Jensen Quality Value Strategy has opportunistically added to its position over the past year to capitalize on its stock price weakness, in the belief that the company’s competitive advantages and growth drivers remain intact.

1 Centers for Medicare and Medicaid Services (CMS)


Strategy holdings are subject to change and should not be considered recommendations to buy or sell any security. For a listing of this Strategy’s current holdings, please click the link below.

Jensen Quality Value Strategy

The discussion of the specific security identified in this article is solely intended to illustrate the application of our investment approach. Our views expressed herein are subject to change and should not be construed as investment advice and are not designed or intended as a basis or determination for making any investment decision for any security. The specific security identified is taken from a representative account of the Jensen Quality Value Composite and does not represent all of the securities purchased and sold for the Strategy. Our discussions should not be construed as an indication that an investment in a security has been or will be profitable, or that the investment recommendations or decisions we make in the future will be profitable or will equal the investment performance of any security discussed herein. This information is current as of the date of this material and is subject to change at any time, based on the market and other conditions. Past performance is no guarantee of future results.

Certain information contained in this material represents or is based upon forward-looking statements, which can be identified by the use of terminology such as “may”, “will”, “should”, “expect”, “anticipate”, “target”, “project”, “estimate”, “intend”, “continue”, or “believe” or the negatives thereof or other variations thereon or comparable terminology. Due to various risks and uncertainties, actual events or results or the actual performance of a client account may differ materially from those reflected or contemplated in such forward-looking statements.

Jensen Investment Management, Inc. is an investment adviser registered under the Investment Advisers Act of 1940. Registration with the SEC does not imply any level of skill or training.

© 2022 Jensen Investment Management.

Interested in Learning More?

Related Insights

Jensen News & Insights

News
4 August 2022
Press Release: Phil Bennett Joins Jensen
On July 11, 2022, Phil Bennett joined Jensen as its new Director of Institutional Sales and Client Service.
false
Mutual Fund, Webinar
3 August 2022
Quality Growth Fund Webinar - Q2 2022
Join Jensen Portfolio Manager Eric Schoenstein for an overview of Q 2022 performance, portfolio activity, market trends, and future outlook.
true
Videos, Webinar
2 August 2022
ESG Investing Webinar
Join Portfolio Manager Kevin Walkush for an in-depth discussion on how Jensen integrates ESG into its investment process.
true
Mutual Fund
2 August 2022
ESG Investing Webinar - Gate
Join Portfolio Manager Kevin Walkush for an in-depth discussion on how Jensen integrates ESG into its investment process.
false
Videos
29 July 2022
Ask a Portfolio Manager: Episode 1
In this webinar series, hosted by Richard Clark, Jensen portfolio managers discuss their high-conviction approaches to investing in the current market.
false
Insights, Mutual Fund, Videos
29 July 2022
Ask a PM - Episode 1 - Gate
Ask a Portfolio Manager: Episode 1 - How does a high-conviction approach to investing work in the current market?
false
Company Highlight
8 July 2022
Company Highlight: Mastercard
The Buy Now Pater Later (BNPL) trend has the potential to disrupt established payment providers. Read our analysis of whether Mastercard's products are at risk.
true
Mutual Fund
21 June 2022
Animal Spirits - 2022
Jensen Portfolio Manager Allen Bond joins the Animal Sprits Podcast to discuss what qualities to look for in quality growth companies and how they perform during inflationary periods.
false
News
13 June 2022
Press Release: Shannon Contreras Appointed to Board of Directors
We are pleased to announce the appointment of Shannon Contreras, Managing Director – Finance, to Jensen's Board of Directors.
false